monoclonal antibody

  1. SNT Gatchaman

    Impact of treatment of COVID-19 with sotrovimab on post-acute sequelae of COVID-19 PASC…, 2025, Drysdale+

    Impact of treatment of COVID-19 with sotrovimab on post-acute sequelae of COVID-19 PASC: an analysis of National COVID Cohort Collaborative N3C data Drysdale, Myriam; Chang, Rose; Guo, Tracy; Duh, Mei Sheng; Han, Jennifer; Birch, Helen; Sharpe, Catherine; Liu, Daisy; Kalia, Sarah; Van Dyke...
  2. SNT Gatchaman

    Post–acute Sequelae of COVID-19 Among Solid Organ Transplant Recipients: Insights From the Omicron Period, 2024, Morená et al.

    Post–acute Sequelae of COVID-19 Among Solid Organ Transplant Recipients: Insights From the Omicron Period Morená, Leela; Al Jurdi, Ayman; El Mouhayyar, Christopher; Verhoeff, Rucháma; Alzahrani, Nora; N. Kotton, Camille; V. Riella, Leonardo BACKGROUND In solid organ transplant recipients...
  3. SNT Gatchaman

    Relapsing-Remitting Immunotherapy Responsive Small-Fiber Neuropathy, 2024, Oaklander et al.

    Relapsing-Remitting Immunotherapy Responsive Small-Fiber Neuropathy Anne Louise Oaklander, Julia Allen, Nadja Dietliker, Einar P. Wilder-Smith OBJECTIVES To expand understanding of the pathogenesis, presentations, and treatment of initially idiopathic small fiber polyneuropathy (SFN). METHODS...
  4. forestglip

    Review The efficacy of antivirals, corticosteroids, and mAbs as acute COVID treatments in reducing the incidence of long COVID, 2024, Gangqiang +

    The efficacy of antivirals, corticosteroids, and mAbs as acute COVID treatments in reducing the incidence of long COVID: a Systematic Review and meta-analysis Gangqiang Sun, Ke Lin, Jingwen Ai, Wenhong Zhang Abstract Background: Whether treatment during acute COVID results in protective...
  5. SNT Gatchaman

    [Preprint] Tocilizumab Reduces Hypercoagulation in COVID-19 - Perspectives from Coag-ImmCovA Clinical Trial, 2024, Almskog et al.

    Tocilizumab Reduces Hypercoagulation in COVID-19 - Perspectives from The Coagulation and Immunomodulation Covid Assessment Coag-ImmCovA Clinical Trial. Lou M Almskog; Anna Sjostrom; Jonas Sunden-Cullberg; Apostolos Taxiarchis; Anna Agren; Sara Freyland; Madeleine Borjesson; Agneta Wikman; Carl...
  6. Andy

    Remission of severe forms of Long Covid following monoclonal antibody (MCA) infusions: A report of signal index cases..., 2024, Scheppke, Klimas et al

    Note: title change in final publication - see post below Preprint Pathophysiology and potential treatment of long COVID: A report of signal index cases and call for targeted research, 2023, Scheppke, Klimas et al Objective Long COVID has afflicted tens of millions globally leaving many...
  7. E

    Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivor, 2023, Chia et al

    Abstract The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern such as Omicron hampered efforts in controlling the ongoing coronavirus disease 2019 pandemic due to their ability to escape neutralizing antibodies induced by vaccination or prior...
Back
Top Bottom